Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH

2010 ◽  
Vol 45 (7) ◽  
pp. 750-757 ◽  
Author(s):  
Yuki Kimura ◽  
Hideyuki Hyogo ◽  
Sho-ichi Yamagishi ◽  
Masayoshi Takeuchi ◽  
Tomokazu Ishitobi ◽  
...  
Hepatology ◽  
2013 ◽  
Vol 58 (4) ◽  
pp. 1339-1348 ◽  
Author(s):  
Joy X. Jiang ◽  
Xiangling Chen ◽  
Hiroo Fukada ◽  
Nobuko Serizawa ◽  
Sridevi Devaraj ◽  
...  

PLoS ONE ◽  
2012 ◽  
Vol 7 (4) ◽  
pp. e35655 ◽  
Author(s):  
Bruce A. Perkins ◽  
Naila Rabbani ◽  
Andrew Weston ◽  
Linda H. Ficociello ◽  
Antonysunil Adaikalakoteswari ◽  
...  

2007 ◽  
Vol 375 (6) ◽  
pp. 401-406 ◽  
Author(s):  
Moritz Butscheid ◽  
Christian Schäfer ◽  
Stefanie Brenner ◽  
Dominik Alscher ◽  
Thomas Mürdter ◽  
...  

2011 ◽  
Vol 487 (1) ◽  
pp. 99-102 ◽  
Author(s):  
Enzo Emanuele ◽  
Valentina Martinelli ◽  
Maria V. Carlin ◽  
Elisabetta Fugazza ◽  
Francesco Barale ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document